Media
Home
Media
Warning: Trying to access array offset on value of type null in /var/www/vhosts/minoryx.com/httpdocs/negocio/plantillas/panels/herointerior/_preprocess.php on line 15
- Press
Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral AdrenoleukodystrophyUS trial with leriglitazone to commence in mid-2023 providing an ...31/05/2023
Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD)Initial evidence of disease stabilization was demonstrated for all patients ...25/04/2023
The Lancet Neurology publishes results from Minoryx Therapeutics Phase 2/3 ADVANCE clinical trial of leriglitazone in X-linked AdrenoleukodystrophyLeriglitazone was well tolerated, and significant benefit was shown through ...20/01/2023Read more
- Events
Events in 2023
22 Jun 2023 - 24 Jun 2023ULF Scientific Symposium and Family ConferenceCHICAGOEvents in 2022Events in 2021Events in 2020Events in 201911 Nov 2019 - 13 Nov 2019World Orphan Drug CongressBARCELONA11 Nov 2019 - 13 Nov 2019BIO-Europe 2019HAMBURG
